Mark Agulnik, MD, FRCPC

Dr. Agulnik’s research focuses on clinical trials. Goals include studying the role and use of molecular targeting agents, novel chemotherapeutics and new approaches for combined chemoradiotherapy for both patients with Sarcomas or Cancers of the Head and Neck.